Stock Market & Financial Investment News

News Breaks September 7, 2012 07:14 EDT CELG Celgene price target raised to $82 from $76 at Cantor Cantor raised its target on Celgene after the company reported results from trials of its apremilast for psoriatic arthritis that the firm views as positive. The firm maintains a Buy rating on the stock. News For CELG From The Last 14 Days Check below for free stories on CELG the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 20, 2013 09:51 EDT CELG Celgene management to meet with JPMorgan Meetings to be held in Boston on May 22-23 hosted by JPMorgan. May 17, 2013 05:51 EDT CELG Stocks with implied volatility movement; CBST CELG Subscribe for More Information May 16, 2013 11:50 EDT CELG Celgene, Gilead lower after new data published at ASCO Subscribe for More Information May 7, 2013 07:18 EDT CELG Barclays has increased confidence in Celgene's re-filing of Revlimid Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.